Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 652


Cognitive Deficits and Related Brain Lesions in Patients With Chronic Heart Failure.

Frey A, Sell R, Homola GA, Malsch C, Kraft P, Gunreben I, Morbach C, Alkonyi B, Schmid E, Colonna I, Hofer E, Müllges W, Ertl G, Heuschmann P, Solymosi L, Schmidt R, Störk S, Stoll G.

JACC Heart Fail. 2018 May 31. pii: S2213-1779(18)30225-7. doi: 10.1016/j.jchf.2018.03.010. [Epub ahead of print]


Value of the CHA2DS2-VASc score and Fabry-specific score for predicting new-onset or recurrent stroke/TIA in Fabry disease patients without atrial fibrillation.

Liu D, Hu K, Schmidt M, Müntze J, Maniuc O, Gensler D, Oder D, Salinger T, Weidemann F, Ertl G, Frantz S, Wanner C, Nordbeck P.

Clin Res Cardiol. 2018 May 24. doi: 10.1007/s00392-018-1285-4. [Epub ahead of print]


Clinical impact of the alpha-galactosidase A gene single nucleotide polymorphism -10C>T: A single-center observational study.

Oder D, Liu D, Üçeyler N, Sommer C, Hu K, Salinger T, Müntze J, Petritsch B, Ertl G, Wanner C, Nordbeck P, Weidemann F.

Medicine (Baltimore). 2018 May;97(21):e10669. doi: 10.1097/MD.0000000000010669.


Safety and feasibility of pulmonary artery pressure-guided heart failure therapy: rationale and design of the prospective CardioMEMS Monitoring Study for Heart Failure (MEMS-HF).

Angermann CE, Assmus B, Anker SD, Brachmann J, Ertl G, Köhler F, Rosenkranz S, Tschöpe C, Adamson PB, Böhm M.

Clin Res Cardiol. 2018 May 19. doi: 10.1007/s00392-018-1281-8. [Epub ahead of print]


Public funding for medical research in relation to the burden of disease caused by cardiovascular diseases and neoplasms in Germany.

Krone M, Dufner V, Wagner M, Gelbrich G, Ertl G, Heuschmann PU.

Clin Res Cardiol. 2018 Apr 13. doi: 10.1007/s00392-018-1240-4. [Epub ahead of print]


CRP genetic variants are associated with mortality and depressive symptoms in chronic heart failure patients.

Kittel-Schneider S, Kaspar M, Berliner D, Weber H, Deckert J, Ertl G, Störk S, Angermann C, Reif A.

Brain Behav Immun. 2018 Jul;71:133-141. doi: 10.1016/j.bbi.2018.04.002. Epub 2018 Apr 5.


[Heart failure in the general medical practice - A guide to diagnosis and therapy].

Güder G, Ertl G.

MMW Fortschr Med. 2018 Mar;160(4):32-38. doi: 10.1007/s15006-018-0242-5. Review. German. No abstract available.


Imaging of C-X-C Motif Chemokine Receptor CXCR4 Expression After Myocardial Infarction With [68Ga]Pentixafor-PET/CT in Correlation With Cardiac MRI.

Reiter T, Kircher M, Schirbel A, Werner RA, Kropf S, Ertl G, Buck AK, Wester HJ, Bauer WR, Lapa C.

JACC Cardiovasc Imaging. 2018 Feb 9. pii: S1936-878X(18)30007-X. doi: 10.1016/j.jcmg.2018.01.001. [Epub ahead of print] No abstract available.


Point-of-care B-type natriuretic peptide and portable echocardiography for assessment of patients with suspected heart failure in primary care: rationale and design of the three-part Handheld-BNP program and results of the training study.

Morbach C, Buck T, Rost C, Peter S, Günther S, Störk S, Prettin C, Erbel R, Ertl G, Angermann CE; Handheld-BNP Research Network.

Clin Res Cardiol. 2018 Feb;107(2):95-107. doi: 10.1007/s00392-017-1181-3. Epub 2017 Nov 15.


Secondary Prevention in Younger vs. Older Coronary Heart Disease Patients-Insights from the German Subset of the EUROASPIRE IV Survey.

Wagner M, Gelbrich G, Kircher J, Kotseva K, Wood D, Morbach C, Leyh R, Ertl G, Karmann W, Störk S, Heuschmann PU.

Int J Behav Med. 2018 Jun;25(3):283-293. doi: 10.1007/s12529-017-9691-y.


PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock.

Thiele H, Akin I, Sandri M, Fuernau G, de Waha S, Meyer-Saraei R, Nordbeck P, Geisler T, Landmesser U, Skurk C, Fach A, Lapp H, Piek JJ, Noc M, Goslar T, Felix SB, Maier LS, Stepinska J, Oldroyd K, Serpytis P, Montalescot G, Barthelemy O, Huber K, Windecker S, Savonitto S, Torremante P, Vrints C, Schneider S, Desch S, Zeymer U; CULPRIT-SHOCK Investigators.

N Engl J Med. 2017 Dec 21;377(25):2419-2432. doi: 10.1056/NEJMoa1710261. Epub 2017 Oct 30.


Thrombus Aspiration for ST-Segment-Elevation Myocardial Infarction in Modern Era: Still an Issue of Debate?

Ge J, Schäfer A, Ertl G, Nordbeck P.

Circ Cardiovasc Interv. 2017 Oct;10(10). pii: e005739. doi: 10.1161/CIRCINTERVENTIONS.117.005739. Review.


α-Galactosidase A Genotype N215S Induces a Specific Cardiac Variant of Fabry Disease.

Oder D, Liu D, Hu K, Üçeyler N, Salinger T, Müntze J, Lorenz K, Kandolf R, Gröne HJ, Sommer C, Ertl G, Wanner C, Nordbeck P.

Circ Cardiovasc Genet. 2017 Oct;10(5). pii: e001691. doi: 10.1161/CIRCGENETICS.116.001691.


[Centers in Health Care: whereto?]

Ertl G.

Dtsch Med Wochenschr. 2017 Oct;142(20):1481. doi: 10.1055/s-0043-111141. Epub 2017 Oct 10. German. No abstract available.


Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease.

HPS3/TIMI55–REVEAL Collaborative Group, Bowman L, Hopewell JC, Chen F, Wallendszus K, Stevens W, Collins R, Wiviott SD, Cannon CP, Braunwald E, Sammons E, Landray MJ.

N Engl J Med. 2017 Sep 28;377(13):1217-1227. doi: 10.1056/NEJMoa1706444. Epub 2017 Aug 28.


Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease.

Eikelboom JW, Connolly SJ, Bosch J, Dagenais GR, Hart RG, Shestakovska O, Diaz R, Alings M, Lonn EM, Anand SS, Widimsky P, Hori M, Avezum A, Piegas LS, Branch KRH, Probstfield J, Bhatt DL, Zhu J, Liang Y, Maggioni AP, Lopez-Jaramillo P, O'Donnell M, Kakkar AK, Fox KAA, Parkhomenko AN, Ertl G, Störk S, Keltai M, Ryden L, Pogosova N, Dans AL, Lanas F, Commerford PJ, Torp-Pedersen C, Guzik TJ, Verhamme PB, Vinereanu D, Kim JH, Tonkin AM, Lewis BS, Felix C, Yusoff K, Steg PG, Metsarinne KP, Cook Bruns N, Misselwitz F, Chen E, Leong D, Yusuf S; COMPASS Investigators.

N Engl J Med. 2017 Oct 5;377(14):1319-1330. doi: 10.1056/NEJMoa1709118. Epub 2017 Aug 27.


Simple screening tools predict death and cardiovascular events in patients with rheumatic disease.

Breunig M, Kleinert S, Lehmann S, Kneitz C, Feuchtenberger M, Tony HP, Angermann CE, Ertl G, Störk S.

Scand J Rheumatol. 2018 Mar;47(2):102-109. doi: 10.1080/03009742.2017.1337924. Epub 2017 Aug 16.


Rationale, Design and Baseline Characteristics of Participants in the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) Trial.

Bosch J, Eikelboom JW, Connolly SJ, Bruns NC, Lanius V, Yuan F, Misselwitz F, Chen E, Diaz R, Alings M, Lonn EM, Widimsky P, Hori M, Avezum A, Piegas LS, Bhatt DL, Branch KRH, Probstfield JL, Liang Y, Liu L, Zhu J, Maggioni AP, Lopez-Jaramillo P, O'Donnell M, Fox KAA, Kakkar A, Parkhomenko AN, Ertl G, Störk S, Keltai K, Keltai M, Ryden L, Dagenais GR, Pogosova N, Dans AL, Lanas F, Commerford PJ, Torp-Pedersen C, Guzik TJ, Verhamme PB, Vinereanu D, Kim JH, Ha JW, Tonkin AM, Varigos JD, Lewis BS, Felix C, Yusoff K, Steg PG, Aboyans V, Metsarinne KP, Anand SS, Hart RG, Lamy A, Moayyedi P, Leong DP, Sharma M, Yusuf S.

Can J Cardiol. 2017 Aug;33(8):1027-1035. doi: 10.1016/j.cjca.2017.06.001. Epub 2017 Jun 8. Review.


[Heart Failure - A Model for Multimorbidity].

Güder G, Ertl G.

Dtsch Med Wochenschr. 2017 Jul;142(14):1054-1060. doi: 10.1055/s-0042-109357. Epub 2017 Jul 20. Review. German.


[Multimorbidity - choosing wisely inspite of lacking data].

Ertl G.

Dtsch Med Wochenschr. 2017 Jul;142(14):1017. doi: 10.1055/s-0043-110015. Epub 2017 Jul 20. German. No abstract available.


Supplemental Content

Loading ...
Support Center